Diamedica Therapeutics Stock Alpha and Beta Analysis
| DMAC Stock | USD 6.29 0.04 0.64% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as DiaMedica Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in DiaMedica Therapeutics over a specified time horizon. Remember, high DiaMedica Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to DiaMedica Therapeutics' market risk premium analysis include:
Beta 0.77 | Alpha 0.71 | Risk 5.83 | Sharpe Ratio 0.14 | Expected Return 0.84 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
DiaMedica |
DiaMedica Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. DiaMedica Therapeutics market risk premium is the additional return an investor will receive from holding DiaMedica Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in DiaMedica Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate DiaMedica Therapeutics' performance over market.| α | 0.71 | β | 0.77 |
DiaMedica Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of DiaMedica Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how DiaMedica Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.DiaMedica Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how DiaMedica Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DiaMedica Therapeutics shares will generate the highest return on investment. By understating and applying DiaMedica Therapeutics stock market price indicators, traders can identify DiaMedica Therapeutics position entry and exit signals to maximize returns.
DiaMedica Therapeutics Return and Market Media
The median price of DiaMedica Therapeutics for the period between Mon, Nov 18, 2024 and Sun, Feb 16, 2025 is 5.43 with a coefficient of variation of 12.42. The daily time series for the period is distributed with a sample standard deviation of 0.67, arithmetic mean of 5.38, and mean deviation of 0.51. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | DMAC Stock Soars to 52-Week High, Hits 4.95 Amid Bullish Run - Investing.com | 11/26/2024 |
2 | Diamedica Stock Soars to 52-Week High, Reaching 5.74 - Investing.com | 12/12/2024 |
3 | Acquisition by Semba Charles Pauling of 5290 shares of DiaMedica Therapeutics at 5.34 subject to Rule 16b-3 | 01/02/2025 |
4 | Acquisition by Kuntz Richard of 9925 shares of DiaMedica Therapeutics at 5.34 subject to Rule 16b-3 | 01/03/2025 |
5 | DiaMedica Therapeutics Trading Down 1.5 percent - Heres Why - MarketBeat | 02/04/2025 |
6 | Learn to Evaluate using the Charts - Stock Traders Daily | 02/13/2025 |
About DiaMedica Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including DiaMedica or other stocks. Alpha measures the amount that position in DiaMedica Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Payables Turnover | 0.0292 | 0.0271 | Days Of Inventory On Hand | 1.5K | 1.6K |
DiaMedica Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of DiaMedica Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DiaMedica Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of DiaMedica Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of DiaMedica Therapeutics. Please utilize our Beneish M Score to check the likelihood of DiaMedica Therapeutics' management manipulating its earnings.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with DiaMedica Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out DiaMedica Therapeutics Backtesting, DiaMedica Therapeutics Valuation, DiaMedica Therapeutics Correlation, DiaMedica Therapeutics Hype Analysis, DiaMedica Therapeutics Volatility, DiaMedica Therapeutics History and analyze DiaMedica Therapeutics Performance. For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
DiaMedica Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.